schizophrenia, dementia, antidepressant, psychiatric

NAMI provides new dimension to Hearts & Minds initiative
The National Alliance on Mental Illness is providing a new dimension to its Hearts & Minds initiative, an educational program that promotes "mind and body" health practices for individuals who live with mental illness.

Latest achievements in brain research and treatment for mental disorders
Mental disorders, such as depression, anxiety disorders, addiction and schizophrenia are the core challenge of most health care systems around the world. In the EU alone, each year 27% of the total adult population - this corresponds to 83 Million citizens - suffer from mental disorders. Depression alone

23rd ECNP Press conference on impact of circadian rhythms on human brain
All humans are synchronised to the rhythmic light-dark changes that occur on a daily basis. Rhythms in physiological and biochemical processes and behavioural patterns persist in the absence of all external 24-hour signals from the physical environment, with a period that is close to 24 hours

23rd ECNP Congress press conference
The incidence of psychotic disorders varies greatly across places and demographic groups, as do symptoms, course, and treatment response across individuals. High rates of schizophrenia in large cities, and among immigrants, cannabis users, and traumatised individuals reflect the causal influence of environmental exposures. This, in combination with progress

Forest Laboratories reveals top-line results from cariprazine Phase II clinical trial for bipolar depression
Forest Laboratories, Inc. and Gedeon Richter Plc. today announced preliminary top-line results from an 8-week Phase II clinical trial of the novel, investigational antipsychotic agent cariprazine for the treatment of bipolar depression. Cariprazine is currently undergoing Phase III trials for separate indications of schizophrenia and bipolar mania.

An overview of Schizophrenia and psychotic disorders
Schizophrenia and related psychotic disorders are a chronic and often disabling condition. Despite modern treatment techniques they still present an enormous burden to the patients and their relatives and take a serious toll in terms of human suffering and societal expenditure.

23rd European College of Neuropsychopharmacology Congress to be held 28 Aug - 1 Sep 2010 in Amsterdam
Mental disorders, such as depression, anxiety disorders, addiction and schizophrenia are the core challenge of most health care systems around the world. In the EU alone, each year 27% of the total adult population - this corresponds to 83 Million citizens - suffer from mental disorders. Depression alone

Neuralstem files IND with FDA for spinal cord stem cell Phase I clinical trial for chronic spinal cord injury
Neuralstem, Inc. announced that it has filed an Investigational New Drug (IND) application with the United States Food and Drug Administration (FDA) to begin a Phase I safety clinical trial for chronic spinal cord injury with its spinal cord stem cells. This multicenter Phase I safety trial will

SureGene collaborates with Medco Health Solutions to conduct REST study
SureGene, LLC and the Medco Research Institute, LLC, a wholly-owned subsidiary of Medco Health Solutions, Inc., today announced that they have entered into a novel investigative research collaboration to evaluate whether variation in genetic biomarkers previously identified by SureGene can help predict drug response for widely prescribed antipsychotic

NARSAD announces 2010 Independent Investigator grants for innovative researchers
NARSAD announced its 2010 Independent Investigator grants totaling in excess of $4.1 million, which will support 42 innovative researchers at the leading edge of discovery within neuroscience and psychiatry. Since 1987 NARSAD has awarded more than $261.6 million in 3,832 grants to 3,132 scientists around the world.

Latest Searches: white, fasr typepad com p12 html, human, youtoupxxx, fasr typepad com p13 html, cancer, sleep, kbadmintonclub, severe, birth, WJGpTVAOKeQyY, hydr ull sho, pharmacy, modular math washington e, medullary, federal. Top Searches...

Common typos for 'Schizophrenia' : schozophenia, sschizo phrenia, schizoph5eniia, sschixophrenia, schizoph-renia, schi-zophrenia, schizpohreniz, schizophre-nia, sfhizophrenia, schiziphrennia, schizophreni-a, shizoph renia, schi zoprenia, schizophr-enia, schizop-hrenia, sxhizophrenia, schihzophrenia, schizophrennia, schizpohreia, schizoprrhenia, schiizoph-renia, schi zophhrenia, shizo-phrenia, schizophreniaa, schizopphreenia, sfhiophrenia, shzophrenia, schizoph5eenia.
More 'Schizophrenia' Typos...